1. Most Discussed
  2. Gainers & Losers
  1. Members, Techs apologise for the loss of thread titles, and are currently working on restoring them. They will be back asap. Thank you
BPO 0.3¢


  1. ortega

    435 Posts.

    Acqn.of Australian Phytochemicals Ltd/Resignation ofDirector

    Document date: Wed 24 Jul 2002 Published: Wed 24 Jul 2002 09:25:41
    Document No: 220005 Document part: A
    Market Flag: Y
    Classification: Asset Acquisition , Director Appointment/Resignation

    HOMEX - Perth

    BioProspect Limited ('BioProspect') is pleased to announce that it
    has signed a Letter of Intent to acquire from Southern Cross
    University ('SCU') the 49% held by it in Australian Phytochemicals
    Limited ('APL').

    The equity held by SCU in APL will be acquired for the issue of three
    million new ordinary shares in BioProspect.

    The philosophy driving this acquisition relates to the current status
    of Qcide and its rapid movement towards commerciality.

    APL holds 7.5% of the intellectual property in terms of net cash
    inflows from sales of Qcide. The acquisition provides now for
    BioProspect to have the equity to control all of the intellectual
    property and, as consequence of that, the cash flow which would be
    derived from the income stream which would have otherwise been
    attributable to APL thereby providing for a more streamlined profile
    for proposed international partners.

    In order to provide a smooth transition of scientific services for
    BioProspect, SCU will provide research and extract services from its
    existing Centre for Phytochemistry. This will provide continuity in
    respect of key members of staff, equipment and facilities.


    Professor Peter Waterman has resigned from the Board of BioProspect
    following his retirement from his position with SCU. However, he will
    continue as Scientific Adviser responsible for new science projects
    and continued research into projects such as the further development
    of Qcide and other new exciting discoveries. The Board of BioProspect
    is delighted that Professor Waterman has decided to continue his
    relationship which will enable him to focus on driving the Company's
    scientific processes.


    As a result of the foregoing initiatives BioProspect will enjoy
    annual cost savings in excess of $500,000 per annum.

    The above arrangements are subject to the finalisation of
    documentation and will be effective from 1 August 2002.

    S Snell

    For further information, please contact:

    Mr Selwyn Snell
    (Ph) 07 3229 5755
    (Fax) 07 3229 4655


    For best results when printing announcements, select landscape rather than portrait as your print option.

    Retrieving the edited text of a company announcement indicates your acceptance of the conditions.

    Terms of use | Privacy Statement
    © Australian Stock Exchange Limited ABN 98 008 624 691

    S&P/ASX indices
    Share prices
    Recent company announcements
    Past company announcements
    Most traded stocks
    Trading volumes
    Historical data
    Company information
    Listed companies
    Delisted companies
    Name & code changes
    ISIN codes
    Recent company announcements
    Past company announcements
    Equities (shares)
    Interest Rate Securities
    Investing in overseas markets
    How the sharemarket works
    How the options market works
    ASX settlement & the role of CHESS
    Choosing a stockbroker
    Company Profile
    ASX announcements
    Speeches & presentations
    ASX share price
    ASX Dividends
    Check your ASX shareholding
    Financial results
    Corporate Calendar
    FAQs - Shareholder
    Contact Us / ASX Share Registry
    Trading volumes
    Upcoming floats
    Recent floats
    Learn about shares
    Learn about options
    Learn about warrants
    Learn about futures
    Learn about interest rate securities
    Learn about ETFs
    Choosing a stockbroker
    ASX Investor Day
    ASX Investor Hour
    ASX games
    Calculators & tools
    ASX Information Source Guide
    ASX / Dymocks Bookshop
    Tax and Stamp Duty
    Company Profile
    Information for companies
    Information for participants
    ASX Media
    National Guarantee Fund
    FAQs - About ASX
    FAQs - About this site
    Careers at ASX
    History of the market
    Trading Calendar
    Contact us
    Interest Rate Securities
    Investing in overseas markets
    Choosing a stockbroker

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.